IE45197L - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
IE45197L
IE45197L IE771001A IE100177A IE45197L IE 45197 L IE45197 L IE 45197L IE 771001 A IE771001 A IE 771001A IE 100177 A IE100177 A IE 100177A IE 45197 L IE45197 L IE 45197L
Authority
IE
Ireland
Prior art keywords
pharmaceutical composition
etilefrin
ergot alkaloid
ca1088865a
venotonics
Prior art date
Application number
IE771001A
Other versions
IE45197B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE45197L publication Critical patent/IE45197L/en
Publication of IE45197B1 publication Critical patent/IE45197B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PHARMACEUTICAL COMPOSITION CONTAINING A HYDROGENATED ERGOT ALKALOID AND ETILEFRIN The invention provides novel pharmaceutical compositions useful as venotonics, comprising a mixture of dihydroergotamine or a related ergot alkaloid and etilefrin. [CA1088865A]
IE1001/77A 1976-05-17 1977-05-16 Improvements in or relating to organic compounds IE45197B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621906 DE2621906A1 (en) 1976-05-17 1976-05-17 NEW THERAPEUTIC MIXTURE AND METHOD FOR PRODUCING IT

Publications (2)

Publication Number Publication Date
IE45197L true IE45197L (en) 1977-11-17
IE45197B1 IE45197B1 (en) 1982-07-14

Family

ID=5978199

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1001/77A IE45197B1 (en) 1976-05-17 1977-05-16 Improvements in or relating to organic compounds

Country Status (22)

Country Link
JP (1) JPS52139730A (en)
AT (1) AT366574B (en)
AU (1) AU513718B2 (en)
BE (1) BE854694A (en)
CA (1) CA1088865A (en)
CS (1) CS207455B2 (en)
DE (1) DE2621906A1 (en)
ES (1) ES458819A1 (en)
FR (1) FR2351657A1 (en)
GB (1) GB1565447A (en)
GR (1) GR72995B (en)
HK (1) HK3283A (en)
HU (1) HU175167B (en)
IE (1) IE45197B1 (en)
IL (1) IL52101A (en)
MY (1) MY8400062A (en)
NL (1) NL177981C (en)
NZ (1) NZ184111A (en)
PH (1) PH20257A (en)
PT (1) PT66552B (en)
SE (1) SE425545B (en)
ZA (1) ZA772935B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (en) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe MEDICINAL PRODUCT
JPH0227013U (en) * 1988-08-10 1990-02-22
WO2000057851A2 (en) 1999-03-26 2000-10-05 Pozen Inc. High potency dihydroergotamine compositions

Also Published As

Publication number Publication date
AU2516977A (en) 1978-11-23
IL52101A0 (en) 1977-07-31
GB1565447A (en) 1980-04-23
BE854694A (en) 1977-11-16
DE2621906C2 (en) 1988-04-21
ATA347677A (en) 1981-09-15
PT66552A (en) 1977-06-01
JPS52139730A (en) 1977-11-21
DE2621906A1 (en) 1977-12-01
FR2351657A1 (en) 1977-12-16
NL177981C (en) 1986-01-02
AT366574B (en) 1982-04-26
AU513718B2 (en) 1980-12-18
NL177981B (en) 1985-08-01
PH20257A (en) 1986-11-14
SE7705340L (en) 1977-11-18
HU175167B (en) 1980-05-28
MY8400062A (en) 1984-12-31
GR72995B (en) 1984-01-24
FR2351657B1 (en) 1980-01-18
SE425545B (en) 1982-10-11
HK3283A (en) 1983-01-20
CA1088865A (en) 1980-11-04
IE45197B1 (en) 1982-07-14
NZ184111A (en) 1980-02-21
ZA772935B (en) 1979-01-31
JPS628413B2 (en) 1987-02-23
IL52101A (en) 1980-01-31
NL7705306A (en) 1977-11-21
CS207455B2 (en) 1981-07-31
PT66552B (en) 1979-09-03
ES458819A1 (en) 1978-08-01

Similar Documents

Publication Publication Date Title
IE781716L (en) Trihydroxypiperidine compounds
IE780932L (en) Cyclosporins (cyclic polypeptides)
EG12773A (en) Processes for the preparation of amidinoureas,the amidinoureas thus produced and compositions incorporating them
IL53419A0 (en) Pharmaceutical compositions containing certain ergot peptide alkaloids
IE790622L (en) Carbamic and thiocarbamic acid derivatives
AU508572B2 (en) Aerosol compositions
IE782475L (en) Compounds
AU508628B2 (en) Ergot alkaloid compositions
DE3069771D1 (en) Novel ergoline derivatives, compositions containing them, their preparation and use as pharmaceuticals
AU502957B2 (en) Oxadiazolinone derivatives and insecticidal compositions containing them
IL54238A (en) Beta-endorphin analogues,their preparation and pharmaceutical compositions containing them
IL61614A (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IE44427L (en) Benzothiadiazole containing composition
IL55315A0 (en) New 4-hydroxy-2-benzimidazolinone derivatives,processes for the preparation thereof and pahrmaceutical compositions containing the same
JPS5328145A (en) Substituted benzoyllureidodiphenylether* process for manufacture thereof and arthropodaakilling composition containing it as active ingredient
IE45197L (en) Pharmaceutical composition
ZA85143B (en) Novel delta4-and delta5-androstene derivatives,processes for their preparation and pharmaceutical compositions containing these derivates
AU534051B2 (en) Ergot alkaloid slow-release compositions
AU499139B2 (en) Slow-release composition containing phentolamine
AU509855B2 (en) Compositions of 1, 2, 4-rhiadiazine derivatives
JPS56156279A (en) Ergoline derivative, its manufacture and medicinal composition containing it
HK40286A (en) Ergot peptide derivatives,their preparation and pharmaceutical compositions containing them
IL56457A0 (en) Ergot peptide alkaloid derivatives, their preparation and pharmaceutical compositions containing them
IE781798L (en) Polypeptides
IL61222A0 (en) Ergot peptide alkaloids, their production and pharmaceutical compositions containing them